[PET (positron emission tomography) research on schizophrenia].
Takano
Akihiro
A
Suhara
Tetsuya
T
D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000494:pharmacology; D001921:Brain / Q000378:metabolism / Q000503:physiopathology; D003342:Corpus Striatum; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D009431:Neural Conduction; D049268:Positron-Emission Tomography; D044282:Receptor, Serotonin, 5-HT1A / Q000378:metabolism / Q000502:physiology; D044402:Receptor, Serotonin, 5-HT2A / Q000378:metabolism / Q000502:physiology; D017447:Receptors, Dopamine D1 / Q000378:metabolism / Q000502:physiology; D017448:Receptors, Dopamine D2 / Q000378:metabolism / Q000502:physiology; D012559:Schizophrenia / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000503:physiopathology
D014150:Antipsychotic Agents; D044402:Receptor, Serotonin, 5-HT2A; D017447:Receptors, Dopamine D1; D017448:Receptors, Dopamine D2; D044282:Receptor, Serotonin, 5-HT1A; D004298:Dopamine